1. 1322 Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in elderly patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. (September 2015) Authors: Kienle, D.; Winterhalder, R.; Koeberle, D.; Horber, D.; Kueng, M.; Saletti, P.; Helbling, D.; Bastian, S.; Dietrich, D.; Baertschi, D.; Pilop, C.; Von Moos, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11). Issue 3 (September 2015) Authors: Cathomas, R.; Crabb, S.; Kenner, H.; Mark, M.; Rothermundt, C.; Elliott, T.; Winterhalder, R.; Von Burg, P.; Berardi Vilei, S.; Hayoz, S.; Rauch, D.; Roggero, E.; Stenner, F.; Berthold, D.; Erdmann, A.; Fischer, N.; Manetsch, G.; Gillessen, S. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 798PImpact of the addition of metformin (Met) to abiraterone (Abi) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) progressing on Abi treatment: A phase II pilot study. (18th September 2017) Authors: Mark, M.; Klingbiel, D.; Mey, U.; Winterhalder, R.; Rothermundt, C.; Gillessen, S.; von Moos, R.; Manetsch, G.; Cathomas, R. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAKK 36/13–IBRUTINIB AND BORTEZOMIB FOLLOWED BY IBRUTINIB MAINTENANCE IN PATIENTS WITH RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA: PHASE I REPORT OF A PHASE I/II TRIAL. (June 2017) Authors: Novak, U.; Fehr, M.; Zander, T.; Winterhalder, R.; Amram, M.; Stathis, A.; Rondeau, S.; Berardi, S.; Eckhardt, K.; Driessen, C.; Renner, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tackling increased risks in older adults with intellectual disability and epilepsy: Data from a national multicentre cohort study. (October 2022) Authors: Watkins, L.V.; Henley, W.; Sun, J.J.; Perera, B.; Angus-Leppan, H.; Sawhney, I.; Purandare, K.; Eyeoyibo, M.; Scheepers, M.; Lines, G.; Winterhalder, R.; Shankar, R. Journal: Seizure Issue: Volume 101(2022) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗